EirGen Pharma Product Dossier Eir-010 submitted in Europe

EirGen Pharma are pleased to report that the dossier for its product Eir-010 was submitted to the Irish Medicines Board via a Decentralized Procedure which will allow Pan-EU approval. This product was successful developed as a treatment for advanced breast cancer and Pan-EU approval is anticipated in early 2010.

EirGen Pharma is a pharmaceutical company based in Waterford, Ireland. Using its purpose built high containment facility; the company specialises in the development, registration and manufacture of high potency solid dose products for global markets.